HENGAN INT'L

Hengan rebounded slightly to HKD 21.80 today, with morning weakness followed by afternoon recovery reflecting market tension between profit decline and cheap valuation support. Year-to-date the stock has dropped 22.86%, sliding 27.24% below its 52-week high of HKD 29.96 and now hovering near the 52-week low of HKD 21.26. 1H26 earnings revealed revenue fell 6.1% to RMB 11.09 billion and net profit declined 8.7% to RMB 1.25 billion, yet gross margin expanded to 35.3% signaling improved cost control. Multiple institutions have cut price targets recently: Citi to HKD 22.8, Jefferies to HKD 23.9, and Morgan Stanley to HKD 23; a dividend yield exceeding 6% (maintaining RMB 0.70 per share) and low multiples (PE 9.05, PB 1.0) provide downside support.

Hengan International closed 1.9% lower at HKD21.68, consistent with the recent analyst consensus downgrade cycle. Citi and Jefferies have both cut their price targets to HKD22.8 and HKD23.9 respectively while maintaining Hold ratings, reflecting cautious sentiment across brokers. The interim results revealed net profit fell 8.7% to RMB1.25 billion and revenue declined 6.1% to RMB11.09 billion, signaling weak consumer demand; however, gross margin expanded to 35.3% and operating profit surged 17-18% year-on-year, demonstrating strong cost control. Valuation appears stretched on the downside: the stock now trades 1.98% above its 52-week low of HKD21.26, down 23.3% year-to-date, with a lean PE ratio of 9x, PB below 1x, and a dividend yield of 7.21%, all near historical lows. Intraday action reflected mounting pressure, with the stock trading in a stable 21.9-22.08 range during the morning session before deteriorating in the afternoon to a daily low of HKD21.62, signaling sustained selling pressure.

Hengan International declined through the morning session to lows of HK$21.86 before recovering to close at HK$22.10, down 0.54% and extending the week's 1.94% loss. 1H26 results showed mixed signals: revenue and net profit fell 6.1% and 8.7% respectively to RMB 11.09B and RMB 1.25B, though gross margin expanded to 35.3% and operating income surged 18.08%, with interim dividend maintained at RMB 0.70 per share. Broker sentiment leaned cautious post-earnings, with Citi cutting its target price to HK$22.8, while Jefferies and Morgan Stanley held targets at HK$23.9 and HK$23.0 respectively, all neutral stances. On valuation, the stock has fallen 21.8% year-to-date, is 26.23% below its 52-week high, sits only 3.95% above the low, and trades below both its 20-day and 60-day moving averages. A low P/E of 9.18x and 7.07% dividend yield provide support.

Hengan held flat at HKD22.22, finding support after recent analyst downgrades. Citi and Jefferies cut price targets to HKD22.8 and HKD23.9 in late August, with current price hovering near these levels; H1 net profit fell 8.7% YoY to RMB1.25B, yet gross margin improved to 35.3% and operating income jumped 17.6%, signaling better cost control and product optimization. The valuation remains compelling—PE ratio at 9.23, dividend yield at 7.03%, and recent capital raise of RMB1B in medium-term notes underpinning financial stability. However, revenue contracted 0.95% YoY and earnings per share posted consecutive negative comparisons, highlighting structural headwinds in the consumer hygiene sector. Year-to-date the stock is down 21.37% from opening, trading near 52-week lows just 4.52% above the trough, caught between attractive valuation and growth concerns.

Hengan International declined 1.33% to HKD 22.22 today, weighed down by disappointing interim results and successive analyst downgrades. First-half revenue fell 6.1% year-over-year to RMB 11.09 billion while net profit dropped 8.7% to RMB 1.25 billion—the core pressure point—though gross margin improved to 35.3%, signaling better cost control. Citi, Jefferies, and Morgan Stanley have all recently trimmed their target prices to the HKD 22.8–23.9 range, reflecting caution on earnings momentum. Viewed through a valuation lens, the stock has slid 21.37% since the start of the year and trades 25% below its 52-week high, yet the depressed P/E multiple of 9.23x and attractive dividend yield of 7.03% present relative value. The company's decision to maintain its interim dividend of RMB 0.70 per share offers some support to the stock, though this alone is unlikely to reverse the underlying headwind from revenue contraction.